News

Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...
Crain's Chicago Business14h
Abbott wins approval for open-heart surgery-free valve replacement
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge
On Friday, the U.S. Food and Drug Administration (FDA) approved Liquidia Corporation’s LQDA Yutrepia (treprostinil) ...
Endpoints News15h
Liq­uidia wins ap­proval for in­haled hy­per­ten­sion drug in two set­tings, fur­ther­ing ri­val­ry with Unit­ed Ther­a­peu­tics
The FDA approved Liquidia’s treprostinil program for two related kinds of high blood pressure, turning up the heat on rival ...